EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Intravenous Paracetamol for Perioperative Shivering Prophylaxis in Patients Undergoing Spinal Anesthesia: A Prospective, Randomized, Double‐Blind Controlled Trial

Thitinuch Ruenhunsa, Saranyoo Nonphiaraj, Donlaya Srikajonkiat, Kanya Panichakul, Sarinya Chanthawong, Chanapat Charoensuk, Peerapong Sangsungnern, Pasit Surakamhaeng

Anesthesiology Research and Practice · 2026-01 · 2026 (1)

DOI: 10.1155/anrp/6133770 ↗
AbstractBibliografische Angaben

Abstract

Background Perioperative shivering (POS) is a common, distressing complication of spinal anesthesia (SA), but a standard prevention has not been identified. This study aimed to determine whether intravenous (IV) paracetamol prevents POS in patients undergoing surgery under SA. Methods In this prospective, randomized, double‐blind controlled trial, 92 patients scheduled for surgery under SA received IV paracetamol 15 mg/kg ( n = 46) or an equal volume of saline ( n = 46) over 15 min before SA. The primary outcome was the overall incidence of POS. The primary analysis was per‐protocol (PP) ( n = 86; paracetamol 42; control 44) after exclusion of 6 patients postrandomization. Post hoc best‐case and worst‐case sensitivity analyses including all 92 patients were also performed. Secondary outcomes included shivering score, shivering duration, rescue pethidine requirements, temperature changes, and adverse events. Results Baseline and intraoperative characteristics were comparable between groups. In the PP analysis, POS incidence was lower with paracetamol than control (26.2% vs. 50.0%; p = 0.023). This was not robust to missing‐data assumptions: the best‐case analysis remained significant (23.9% vs. 52.2%; p = 0.005), but the worst‐case analysis did not (32.6% vs. 47.8%; p = 0.137), and the fragility index was 2. Intraoperative shivering occurred in 4.8% vs. 22.7% ( p = 0.016). Paracetamol also demonstrated lower highest shivering score ( p = 0.039), shorter duration of shivering ( p = 0.031), and less rescue pethidine use ( p = 0.019). There were no statistically significant differences in temperature changes, hypothermia, or nausea and vomiting between groups. Conclusions In the PP analysis, prophylactic IV paracetamol was associated with a lower incidence, severity, and duration of POS and a lower need for rescue pethidine use. However, the primary finding was not robust under worst‐case assumptions (fragility index 2); larger confirmatory trials are warranted. Trial Registration: Thai Clinical Trials Registry: TCTR20210209004.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →